These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33168396)

  • 1. Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.
    Tomaszewski EL; Orchard TJ; Hawkins M; Conway BN; Buchanich JM; Maynard J; Songer T; Costacou T
    J Diabetes Complications; 2021 Feb; 35(2):107770. PubMed ID: 33168396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.
    Tomaszewski EL; Orchard TJ; Hawkins MS; Conway RBN; Buchanich JM; Maynard J; Songer T; Costacou T
    J Diabetes Sci Technol; 2021 Nov; 15(6):1368-1376. PubMed ID: 33993770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
    Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes.
    Conway BN; Aroda VR; Maynard JD; Matter N; Fernandez S; Ratner RE; Orchard TJ
    Diabetes Care; 2012 Nov; 35(11):2331-6. PubMed ID: 22851597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.
    Aroda VR; Conway BN; Fernandez SJ; Matter NI; Maynard JD; Orchard TJ; Ratner RE
    Diabetes Technol Ther; 2013 Feb; 15(2):117-23. PubMed ID: 23305087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.
    Conway B; Edmundowicz D; Matter N; Maynard J; Orchard T
    Diabetes Technol Ther; 2010 May; 12(5):339-45. PubMed ID: 20388043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
    Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
    J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BEK; Horak KL; Maynard JD; Lee KE; Klein R
    Ophthalmic Epidemiol; 2017 Aug; 24(4):211-216. PubMed ID: 28287861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of advanced glycation endproducts estimated from skin fluorescence in first-degree relatives: the impact of adjustment for skin pigmentation.
    Báez EA; Shah S; Felipe D; Maynard J; Chalew S
    J Diabetes Sci Technol; 2015 Mar; 9(2):278-81. PubMed ID: 25411062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.
    Eny KM; Orchard TJ; Miller RG; Maynard J; Grant DM; Costacou T; Cleary PA; Braffett BH; Paterson AD;
    Diabetes Technol Ther; 2015 Oct; 17(10):726-34. PubMed ID: 26192006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of shoulder activity and skin intrinsic fluorescence with low level shoulder pain and disability in people with type 2 diabetes.
    Sorensen CJ; Hastings MK; Lang CE; McGill JB; Clark BR; Bohnert KL; Mueller MJ
    J Diabetes Complications; 2017 Jun; 31(6):983-987. PubMed ID: 28392042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth.
    Báez EA; Shah S; Felipe D; Maynard J; Lefevre S; Chalew SA
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):133-7. PubMed ID: 25153561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
    Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Skin Intrinsic Fluorescence--an Indicator of Advanced Glycation End Products-and Upper Extremity Impairments in Individuals With Diabetes Mellitus.
    Shah KM; Clark BR; McGill JB; Lang CE; Maynard J; Mueller MJ
    Phys Ther; 2015 Aug; 95(8):1111-9. PubMed ID: 25858973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts in children with diabetes.
    Shah S; Baez EA; Felipe DL; Maynard JD; Hempe JM; Chalew SA
    J Pediatr; 2013 Nov; 163(5):1427-31. PubMed ID: 23919908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study.
    Waqas K; Chen J; Koromani F; Trajanoska K; van der Eerden BC; Uitterlinden AG; Rivadeneira F; Zillikens MC
    J Bone Miner Res; 2020 Oct; 35(10):1904-1913. PubMed ID: 32463533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
    Fokkens BT; Smit AJ
    Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.